T. Rowe Price Associates’s Audentes Therapeutics, Inc BOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-394,539
| Closed | -$11.1M | – | 2566 |
|
|
2019
Q3 | $11.1M | Sell |
394,539
-232,342
| -37% | -$6.53M | ﹤0.01% | 1271 |
|
|
2019
Q2 | $23.7M | Sell |
626,881
-163,987
| -21% | -$6.21M | ﹤0.01% | 1130 |
|
|
2019
Q1 | $30.9M | Sell |
790,868
-100,313
| -11% | -$3.91M | ﹤0.01% | 1035 |
|
|
2018
Q4 | $19M | Sell |
891,181
-1,423,423
| -61% | -$30.3M | ﹤0.01% | 1162 |
|
|
2018
Q3 | $91.6M | Sell |
2,314,604
-21,700
| -0.9% | -$859K | 0.01% | 698 |
|
|
2018
Q2 | $89.3M | Buy |
2,336,304
+526,216
| +29% | +$20.1M | 0.01% | 696 |
|
|
2018
Q1 | $54.4M | Buy |
1,810,088
+264,711
| +17% | +$7.95M | 0.01% | 836 |
|
|
2017
Q4 | $48.3M | Buy |
1,545,377
+967,035
| +167% | +$30.2M | 0.01% | 879 |
|
|
2017
Q3 | $16.2M | Sell |
578,342
-23,600
| -4% | -$661K | ﹤0.01% | 1234 |
|
|
2017
Q2 | $11.5M | Buy |
601,942
+41,545
| +7% | +$795K | ﹤0.01% | 1295 |
|
|
2017
Q1 | $9.55M | Sell |
560,397
-18,200
| -3% | -$310K | ﹤0.01% | 1339 |
|
|
2016
Q4 | $10.3M | Sell |
578,597
-1,084
| -0.2% | -$19.2K | ﹤0.01% | 1310 |
|
|
2016
Q3 | $10M | Buy |
+579,681
| New | +$10M | ﹤0.01% | 1318 |
|